CPB2 and inflammatory bowel disease: In addition, in patients with IBD, decreased levels of protein C and protein S, increased plasma levels of PAI-1, and reduced plasma levels of thrombin-activatable fibrinolysis inhibitor (TAFI) were found, indicating the imbalance of fibrinolysis in IBD [35,37].